# Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy

> **NCT01102946** · PHASE2 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 40 (actual)

## Conditions studied

- Diabetic Retinopathy
- Retinal Neovascularization

## Interventions

- **DRUG:** Ranibizumab
- **PROCEDURE:** Panretinal Photocoagulation

## Key facts

- **NCT ID:** NCT01102946
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2011-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01102946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01102946, "Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01102946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*